Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

453 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort.
Kissling E, Pozo F, Buda S, Vilcu AM, Gherasim A, Brytting M, Domegan L, Gómez V, Meijer A, Lazar M, Vučina VV, Dürrwald R, van der Werf S, Larrauri A, Enkirch T, O'Donnell J, Guiomar R, Hooiveld M, Petrović G, Stoian E, Penttinen P, Valenciano M; I-MOVE primary care study team. Kissling E, et al. Among authors: van der werf s. Euro Surveill. 2019 Nov;24(48):1900604. doi: 10.2807/1560-7917.ES.2019.24.48.1900604. Euro Surveill. 2019. PMID: 31796152 Free PMC article.
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.
Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M; European Influenza Surveillance Scheme. Meijer A, et al. Among authors: van de kassteele j, van der werf s. Emerg Infect Dis. 2009 Apr;15(4):552-60. doi: 10.3201/eid1504.181280. Emerg Infect Dis. 2009. PMID: 19331731 Free PMC article.
HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains.
Luytjes W, Enouf V, Schipper M, Gijzen K, Liu WM, van der Lubben M, Meijer A, van der Werf S, Soethout EC. Luytjes W, et al. Among authors: van der lubben m, van der werf s. Vaccine. 2012 Jul 27;30(35):5262-9. doi: 10.1016/j.vaccine.2012.05.060. Epub 2012 Jun 9. Vaccine. 2012. PMID: 22691431 Clinical Trial.
Emerging highly pathogenic H5 avian influenza viruses in France during winter 2015/16: phylogenetic analyses and markers for zoonotic potential.
Briand FX, Schmitz A, Ogor K, Le Prioux A, Guillou-Cloarec C, Guillemoto C, Allée C, Le Bras MO, Hirchaud E, Quenault H, Touzain F, Cherbonnel-Pansart M, Lemaitre E, Courtillon C, Gares H, Daniel P, Fediaevsky A, Massin P, Blanchard Y, Eterradossi N, van der Werf S, Jestin V, Niqueux E. Briand FX, et al. Among authors: van der werf s. Euro Surveill. 2017 Mar 2;22(9):30473. doi: 10.2807/1560-7917.ES.2017.22.9.30473. Euro Surveill. 2017. PMID: 28277218 Free PMC article.
Performance of influenza case definitions for influenza community surveillance: based on the French influenza surveillance network GROG, 2009-2014.
Casalegno JS, Eibach D, Valette M, Enouf V, Daviaud I, Behillil S, Vabret A, Soulary JC, Benchaib M, Cohen JM, van der Werf S, Mosnier A, Lina B. Casalegno JS, et al. Among authors: van der werf s. Euro Surveill. 2017 Apr 6;22(14):30504. doi: 10.2807/1560-7917.ES.2017.22.14.30504. Euro Surveill. 2017. PMID: 28422004 Free PMC article.
2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children.
Kissling E, Valenciano M, Pozo F, Vilcu AM, Reuss A, Rizzo C, Larrauri A, Horváth JK, Brytting M, Domegan L, Korczyńska M, Meijer A, Machado A, Ivanciuc A, Višekruna Vučina V, van der Werf S, Schweiger B, Bella A, Gherasim A, Ferenczi A, Zakikhany K, O Donnell J, Paradowska-Stankiewicz I, Dijkstra F, Guiomar R, Lazar M, Kurečić Filipović S, Johansen K, Moren A; I-MOVE/I-MOVE+ study team. Kissling E, et al. Among authors: van der werf s. Influenza Other Respir Viruses. 2018 Jul;12(4):423-437. doi: 10.1111/irv.12520. Epub 2018 Mar 14. Influenza Other Respir Viruses. 2018. PMID: 29125681 Free PMC article.
Erratum to "Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition consultation for northern hemisphere 2017/18" [Vaccine 35 (2017) 4828-4835].
Melidou A, Broberg E; European region influenza surveillance network. Melidou A, et al. Vaccine. 2018 May 3;36(19):2740-2741. doi: 10.1016/j.vaccine.2017.12.039. Epub 2017 Dec 20. Vaccine. 2018. PMID: 29274700 Free article. No abstract available.
Influenza epidemics observed in primary care from 1984 to 2017 in France: A decrease in epidemic size over time.
Souty C, Amoros P, Falchi A, Capai L, Bonmarin I, van der Werf S, Masse S, Turbelin C, Rossignol L, Vilcu AM, Lévy-Bruhl D, Lina B, Minodier L, Dorléans Y, Guerrisi C, Hanslik T, Blanchon T. Souty C, et al. Among authors: van der werf s. Influenza Other Respir Viruses. 2019 Mar;13(2):148-157. doi: 10.1111/irv.12620. Epub 2019 Jan 18. Influenza Other Respir Viruses. 2019. PMID: 30428158 Free PMC article.
453 results